Your session is about to expire
← Back to Search
Orthotics
3D-Printed Orthotics for Plantar Fasciitis
N/A
Waitlist Available
Research Sponsored by Prisma Health-Midlands
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial will compare 3D printed custom orthotics to traditional ones to see if they can help with 77% of Americans' foot pain, often caused by plantar fasciitis.
Who is the study for?
This trial is for adults over 18 with plantar fasciitis who can communicate electronically. It's not suitable for non-English speakers, Medicare patients, pregnant women, those needing lower leg bracing, or individuals with a history of orthotic use or certain foot conditions.Check my eligibility
What is being tested?
The study compares the effectiveness and patient satisfaction between HP Arize 3D-printed orthotics and traditional custom-made ones in treating plantar fasciitis. Participants will receive one type to see which performs better.See study design
What are the potential side effects?
While specific side effects are not listed for wearing orthotics, some may experience discomfort or pain during initial use as their feet adjust to the new support provided by the inserts.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient-reported compliance and satisfaction with orthotics.
Secondary outcome measures
Patient-reported secondary site pain following implementation of orthotics.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HP Arize 3D-Printed OrthoticsExperimental Treatment1 Intervention
Patients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Group II: Traditional OrthoticsActive Control1 Intervention
Patients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.
Find a Location
Who is running the clinical trial?
Hewlett-Packard (HP)UNKNOWN
Prisma Health-MidlandsLead Sponsor
23 Previous Clinical Trials
2,796 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have used or been prescribed orthotic inserts in the past.You have been diagnosed with nerve damage, a recent broken bone, or a bone fracture caused by overuse or repetitive stress.You need to wear extra support on your lower leg.You have been diagnosed with plantar fasciitis.
Research Study Groups:
This trial has the following groups:- Group 1: Traditional Orthotics
- Group 2: HP Arize 3D-Printed Orthotics
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is eligibility for this research restricted to adults of a certain age?
"This clinical study is open to individuals aged 18 and over, up until the age of 100."
Answered by AI
Who can be accepted into this trial based on the criteria set forth?
"To qualify for this clinical trial, individuals should be between the ages of 18 and 100 with a diagnosis of plantar fasciitis. Additionally, 30 participants need to be recruited in total."
Answered by AI
Are any additional participants being recruited for this medical study?
"Clinicialtrials.gov indicates that this clinical trial, initially proposed on January 19th 2023, is not actively recruiting patients. Meanwhile, 22 other studies are in the process of enrolling volunteers at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger